KRT19 and breast cancer: When the study was implemented, the kit for the assay of lung cancer LNs was not yet available and that was why published studies, including ours, employed kits for assays of LNs obtained from patients with breast cancer, including the set cut-off value, which was 250 copies of mRNA of CK19/μL.